A highly sensitive cell assay for validation of purification regimes of alginates

Biomaterials

Volumn 24, Issue 23, 2003, Pages 4161-4172

  Leinfelder, U ^a   Brunnenmeier, F ^a   Cramer, H ^a   Schiller, J ^b   Arnold, K ^b   Vasquez J A ^c   Zimmermann, U ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSIDAD CATÓLICA DEL NORTE   (Chile)

Author keywords

Alginate; Apoptosis; Bacterial spores; Fibrosis; Immune reaction; Implantation

Indexed keywords

BACTERIA; BIOASSAY; BIOCOMPATIBILITY; HYDROGELS; IMMUNOLOGY; TISSUE CULTURE; TRANSPLANTS;

MICROENCAPSULATION;

ALGAE;

ALGINIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; BACTERIAL SPORE; CELL ASSAY; CELL ENCAPSULATION; CONTROLLED STUDY; FIBROSIS; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN CELL; HYDROGEL; LEUKEMIA CELL LINE; LYMPHOCYTE; MALE; MICROENCAPSULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; TRANSPLANTATION; VALIDATION PROCESS;

ALGAE; BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 0037678411     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00299-0     Document Type: Article

References (46)

1. Kühtreiber W.M., Lanza R.P., Chick W.L. Cell encapsulation technology and therapeutics. 1999;Birkhäuser, Boston, MA.
2. Hunkeler D., Cherrington A., Prokop A., Rajotte R. Bioartificial organs III. Tissue sourcing, immunoisolation and clinical trials. 2001;Annals of the New York Academy of Sciences, New York.
3. Clayton H.A., James R.F.L., London N.J.M. Islet microencapsulation. a review Acta Diabetol. 30:1993;181-189.
4. De Vos P., van Schilfgaarde R. Biocompatibility issues. Kühtreiber W.M., Lanza R.P., Chick W.L. Cell encapsulation technology and therapeutics. 1999;63-75 Birkhäuser, Boston, MA.
5. Zimmermann U., Mimietz S., Zimmermann H., Hillgärtner M., Schneider H., Ludwig J., Hasse C., Haase A., Rothmund M., Fuhr G. Hydrogel-based non-autologous cell and tissue therapy. Biotechniques. 29:2000;564-581.
6. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:1980;908-910.
7. Parker W., Saadi S., Lin S.S., Holzknecht Z.E., Bustos M., Platt J. Transplantation of discordant xenografts. a challenge revisited Immunol Today. 17:1996;373-378.
8. Wijsman J., Atkinson P., Mazaheri R., Garcia B., Paul T., Vose J., O'Shea G., Stiller C. Histological and immunopathological analysis of recovered encapsulated allogeneic islets from transplanted diabetic BB/W rats. Transplantation. 54:1992;588-592.
9. Storrs R, Dorian R, King SR, Lakey J, Rilo H. Preclinical development of the islet sheet. In: Hunkeler D, Cherrington A, Prokop A, Rajotte R, editors. Bioartificial organs III. Tissue sourcing, immunoisolation and clinical trials. Ann NY Acad Sci 2001;944:252-66.
10. Hasse C., Klöck G., Schlosser A., Zimmermann U., Rothmund M. Parathyroid allotransplantation without immunosuppression. Lancet. 350:1997;1296-1297.
11. Zimmermann U., Klöck G., Federlin K., Hannig K., Kowalski M., Bretzel R.G., Horcher A., Entenmann H., Sieber U., Zekorn T.D.C. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis. 13:1992;269-274.
12. Zimmermann U., Cramer H., Jork A., Thürmer F., Zimmermann H., Fuhr G., Hasse C., Rothmund M. Microencapsulation-based cell therapy. Reed G., Rehm H.J. Biotechnology. 2001;547-571 Wiley-VCH, Weinheim.
13. ASTM. Standard guide for characterisation and testing of alginates as starting materials intended for use in biomedical and tissue-engineered medical products application. 2000;F 2064-00.
14. Dornish M, Kaplan D, Skaugrud Ø. Standards and guidelines for biopolymers in tissue-engineered medical products. In: Hunkeler D, Cherrington A, Prokop A, Rajotte R, editors. Bioartificial organs III. Tissue sourcing, immunoisolation and clinical trials. Ann NY Acad Sci 2001;944:388-97.
15. Zimmermann U., Hasse C., Rothmund M., Kühtreiber W. Biocompatible encapsulation materials. fundamentals and application Kühtreiber W.M., Lanza R.P., Chick W.L. Cell encapsulation technology and therapeutics. 1999;40-52 Birkhäuser, Boston, MA.
16. Jork A., Thürmer F., Cramer H., Zimmermann G., Gessner P., Hämel K., Hofmann G., Kuttler B., Hahn H.J., Josimovic-Alasevic O., Fritsch K.G., Zimmermann U. Biocompatible alginate from freshly collected Laminaria pallida for implantation. Appl Microbiol Biotechnol. 53:2000;224-229.
17. Skjåk-Bræk G., Murano E., Paoletti S. Alginate as immobilisation material. II. Determination of polyphenol contaminants by fluorescence spectroscopy, and evaluation of methods for their removal Biotechnol Bioeng. 33:1989;90-94.
18. Wandrey C., Vidal D.S. Purification of polymeric biomaterials. Ann NY Acad Sci. 944:2001;187-198.
19. Steginsky C.A., Beale J.M., Floss H.G., Mayer R.M. Structural determination of alginic acid and the effects of calcium binding as determined by high-field n. m. r. Carbohydrate Res. 225:1992;11-26.
20. Grizzi I., Braud C., Vert M. Calcium alginate dressings I. Physico-chemical characterization and effect of sterilization. J Biomater Sci Polym Ed. 9:1998;189-204.
21. 1H n.m.r. studies of vertebrate blood and plasma. Biochem J. 211:1983;605-615.
22. Braun S., Kalinowski H.-O., Berger S. 150 and more basic NMR experiments. 1998;Wiley-VCH, Weinheim.
23. 19F-labelled alginate gels. production, biocompatibility, stability, and long-term monitoring of functional integrity Math-Wiss u Werkstofftech. 30:1999;783-792.
24. Dulieu C., Poncelet D., Neufeld R.J. Encapsulation and immobilization techniques. Kühtreiber W.M., Lanza R.P., Chick W.L. Cell encapsulation technology and therapeutics. 1999;3-17 Birkhäuser, Boston, MA.
25. Friedrich U., Stachowicz N., Simm A., Fuhr G., Lucas K., Zimmermann U. High efficiency electrotransfection with aluminium electrodes using microsecond controlled pulses. Bioelectrochem Bioenergy. 47:1998;103-111.
26. Amstad P.A., Yu G., Johnson G.L., Lee B.W., Dhawan S., Phelps D.J. An in situ marker for the detection of activated caspases. Am Biot Lab. 18:2000;52-54.
27. Johnson N., Ng T.C.T., Parkin J.M. Camptothecin causes cell cycle perturbations within T-lymphoblastoid cells followed by dose dependent induction of apoptosis. Leuk Res. 21:1997;961-972.
28. Rothenberg M.L. Topoisomerase I inhibitors. review and update Ann Oncol. 8:1997;837-855.
29. Djuzenova C.S., Sukhorukov V.L., Klöck G., Arnold W.M., Zimmermann U. Effect of electric field pulses on the viability and on the membrane-bound immunoglobulins of LPS-activated murine B-lymphocytes. correlation with the cell cycle Cytometry. 15:1994;35-45.
30. Smiley S.T., Reers M., Mottola-Hartshorn C., Lin M., Chen A., Smith T.W., Steele G.D. Jr., Chen L.B. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate-forming lipophilic cation JC-1. Proc Natl Acad Sci. 88:1991;3671-3675.
31. Salvioli S., Ardizzoni A., Franceschi C., Cossarizza A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells. implications for studies on mitochondrial functionality during apoptosis FEBS. 411:1997;77-82.
32. Kroemer G., Dallaporta B., Resche-Rigon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol. 60:1998;619-642.
33. Kulkarni G.V., Lee W., Seth A., McCulloch C.A. Role of mitochondrial membrane potential in concanavalin A-induced apoptosis in human fibroblasts. Exp Cell Res. 245:1998;170-178.
34. Bernardi P., Scorrano L., Colonna R., Petronilli V., Di Lisa F. Mitochondria and cell death. Mechanistic aspects and methodological issues. Eur J Biochem. 264:1999;687-701.
35. Pique M., Barragan M., Dalmau M., Bellosillo B., Pons G., Gil J. Aspirin induces apoptosis through mitochondrial cytochrome c release. FEBS. 480:2000;193-196.
36. Petit P.X., Gendron M.C., Schrantz N., Metivier D., Kroemer G., Maciorowska Z., Sureau F., Koester S. Oxidation of pyridine nucleotides during Fas- and ceramide-induced apoptosis in Jurkat cells. correlation with changes in mitochondria, glutathione depletion, intracellular acidification and caspase 3 activation Biochem J. 353:2001;357-367.
37. 1H magnetization transfer imaging in vivo. Magn Resonance Med. 17:1991;304-314.
38. Lawrence AA. Edible gums, related substances. Park Ridge, NJ: Noyes Data Corporation; 1973. p. 129-64.
39. Shepherd V.A., Beilby M.J. The effect of an extracellular mucilage on the response to osmotic shock in the charophyte alga Lamprothamnium populosum. J Membr Biol. 170:1999;229-242.
40. Zimmermann H., Hillgärtner M., Manz B., Feilen P., Brunnenmeier F., Leinfelder U., Weber M., Cramer H., Schneider S., Hendrich C., Volke F., Zimmermman U. Fabrication of homogeneously cross-linked, functional alginate microcapsules validated by NMR-, CLSM- and AFM-imaging. Biomaterials. 24:2003;2083-2096.
41. Helgason E., Økstad O.A., Caugant D.A., Johansen H.A., Fout A., Mock M., Hegna I., Kolstø A.B. Bacillus anthracis, Bacillus cereus, and Bacillus thuringiensis - one species on basis of genetic evidence. Appl Environ Microbiol. 66:2000;2627-2630.
42. Choopun N., Louis V., Huq A., Colwell R.R. Simple procedure for rapid identification of Vibrio cholerae from the aquatic environment. Appl Environ Microbiol. 68:2002;995-998.
43. Colwell R.R. A voyage of discovery; cholera, climate and complexity. Environ Microbiol. 4:2002;67-69.
44. Madigan M.T., Martinko J.M., Parker J. Brock mikrobiologie. 2001;Spektrum Akademischer Verlag, Heidelberg.
45. Zimmermann U., Thürmer F., Jork A., Weber M., Mimietz S., Hillgärtner M., Brunnenmeier F., Zimmermann H., Westphal I., Fuhr G., Nöth U., Haase A., Steinert A., Hendrich C. A novel class of amitogenic alginate microcapsules for long-term immunoisolated transplantation. Ann NY Acad Sci. 944:2001;199-215.
46. Arfors K.E., Ley K. Sulfated polysaccharides in inflammation. J Lab Clin Med. 121:1993;201-202.